Emma Groarke: Somatic Mutations and Chromosomal Abnormalities in Bone Marrow Failure
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Journals, adding:
“Really excited to see our National Heart, Lung, and Blood Institute How-I-Treat now published in this week’s issue of Blood Journals Portfolio !
Our aim was to provide a practical clinical guide to the interpretation of chromosomal abnormalities and somatic mutations in the context of both immune and germline bone marrow failure. Such somatic alterations can be incorporated into the diagnosis and surveillance for patients with BMF!
We also specifically provide a (hopefully) useful guideline for interpreting somatic mutations / abnormal karyotype before and after IST for SAA
Thanks to my colleagues Bhavisha Patel and Fernanda Gutierrez-Rodrigues, PhD my forever co-authors !”
Title: How I utilize somatic alterations in the diagnosis, risk stratification, and therapy of hypocellular bone marrow failure
Authors: Emma M. Groarke, Fernanda Gutierrez-Rodrigues, Bhavisha A. Patel
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 11:06Houman Khosravani: Stroke and Thrombosis – Bridging Neurology and Hemostasis
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH